108 related articles for article (PubMed ID: 1917523)
1. Dosimetry and pharmacokinetics of monoclonal antibody A6H with human renal cell carcinoma xenografts: single dose study.
Palme DF; Berkopec JM; Wessels BW; Elson MK; Lange PH; Vessella RL
Int J Rad Appl Instrum B; 1991; 18(5):527-37. PubMed ID: 1917523
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model.
Chiou RK; Vessella RL; Limas C; Shafer RB; Elson MK; Arfman EW; Lange PH
Cancer; 1988 May; 61(9):1766-75. PubMed ID: 2451555
[TBL] [Abstract][Full Text] [Related]
3. The impact of tumor size on the efficacy of monoclonal antibody-targeted radiotherapy: studies using a nude mouse model with human renal cell carcinoma xenografts.
Chiou RK
J Urol; 1991 Jul; 146(1):232-7. PubMed ID: 2056596
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and radioimmunoscintigraphy studies of renal cell carcinoma using tumor-preferential monoclonal antibodies and F(ab')2 fragments.
Chiou RK
J Urol; 1989 Dec; 142(6):1584-8. PubMed ID: 2585642
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts.
Wessels BW; Vessella RL; Palme DF; Berkopec JM; Smith GK; Bradley EW
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1257-63. PubMed ID: 2599909
[TBL] [Abstract][Full Text] [Related]
6. Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody.
Chiou RK; Vessella RL; Elson MK; Clayman RV; Gonzalez-Campoy JM; Klicka MJ; Shafer RB; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6140-6. PubMed ID: 2415239
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fresh tissue incubation assay and the in vivo localization of monoclonal antibodies to renal cell carcinoma.
Chiou RK; Vessella RL; Elson MK; Palme DF; Lange PH
J Urol; 1987 Jun; 137(6):1274-7. PubMed ID: 3586173
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in human renal cell carcinoma and their use in radioimmune localization and therapy of tumor xenografts.
Lange PH; Vessella RL; Chiou RK; Elson MK; Moon TD; Palme D; Shafer RK
Surgery; 1985 Aug; 98(2):143-50. PubMed ID: 4023915
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts.
Vessella RL; Alvarez V; Chiou RK; Rodwell J; Elson M; Palme D; Shafer R; Lange P
NCI Monogr; 1987; (3):159-67. PubMed ID: 3821914
[TBL] [Abstract][Full Text] [Related]
10. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
11. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice.
Vessella RL; Lange PH; Palme DF; Chiou RK; Elson MK; Wessels BW
Targeted Diagn Ther; 1988; 1():245-82. PubMed ID: 2979058
[No Abstract] [Full Text] [Related]
13. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2.
Wilbur DS; Vessella RL; Stray JE; Goffe DK; Blouke KA; Atcher RW
Nucl Med Biol; 1993 Nov; 20(8):917-27. PubMed ID: 8298571
[TBL] [Abstract][Full Text] [Related]
15. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
[TBL] [Abstract][Full Text] [Related]
16. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
17. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts.
Kranenborg MH; Boerman OC; de Weijert MC; Oosterwijk-Wakka JC; Corstens FH; Oosterwijk E
Cancer; 1997 Dec; 80(12 Suppl):2390-7. PubMed ID: 9406688
[TBL] [Abstract][Full Text] [Related]
18. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
Sautter-Bihl ML; Wessely R; Bihl H
Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
[TBL] [Abstract][Full Text] [Related]
20. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]